Name | Number of supported studies | Average coverage | |
---|---|---|---|
conventional dendritic cell | 8 studies | 30% ± 14% | |
classical monocyte | 8 studies | 22% ± 4% | |
non-classical monocyte | 8 studies | 25% ± 8% | |
dendritic cell | 7 studies | 30% ± 15% | |
B cell | 5 studies | 23% ± 6% | |
macrophage | 4 studies | 23% ± 7% | |
myeloid cell | 3 studies | 25% ± 10% |
Insufficient scRNA-seq data for expression of NRROS at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 614.50 | 458 / 459 | 96% | 7.68 | 1072 / 1118 |
lung | 100% | 956.21 | 578 / 578 | 94% | 8.82 | 1084 / 1155 |
thymus | 90% | 279.13 | 586 / 653 | 98% | 10.80 | 595 / 605 |
skin | 75% | 177.42 | 1362 / 1809 | 100% | 44.95 | 472 / 472 |
uterus | 98% | 380.85 | 166 / 170 | 75% | 5.27 | 346 / 459 |
intestine | 97% | 362.67 | 937 / 966 | 74% | 4.05 | 391 / 527 |
kidney | 87% | 257.37 | 77 / 89 | 84% | 8.78 | 755 / 901 |
bladder | 100% | 501.76 | 21 / 21 | 70% | 4.55 | 354 / 504 |
prostate | 92% | 247.74 | 226 / 245 | 73% | 3.03 | 367 / 502 |
adrenal gland | 92% | 264.56 | 237 / 258 | 73% | 4.74 | 169 / 230 |
esophagus | 87% | 372.86 | 1260 / 1445 | 75% | 3.93 | 137 / 183 |
brain | 59% | 104.72 | 1555 / 2642 | 97% | 9.69 | 682 / 705 |
stomach | 73% | 193.77 | 261 / 359 | 83% | 5.31 | 236 / 286 |
ovary | 56% | 123.48 | 100 / 180 | 93% | 7.10 | 398 / 430 |
liver | 50% | 91.82 | 112 / 226 | 67% | 3.26 | 274 / 406 |
pancreas | 25% | 40.93 | 83 / 328 | 87% | 5.74 | 155 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 37.93 | 80 / 80 |
spleen | 100% | 1816.09 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 1876.48 | 928 / 929 | 0% | 0 | 0 / 0 |
adipose | 100% | 874.88 | 1199 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 46.60 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 84% | 7.46 | 38 / 45 |
heart | 78% | 172.85 | 670 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 76% | 266.28 | 1021 / 1335 | 0% | 0 | 0 / 0 |
muscle | 31% | 46.25 | 248 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0014005 | Biological process | microglia development |
GO_0035583 | Biological process | sequestering of TGFbeta in extracellular matrix |
GO_0006801 | Biological process | superoxide metabolic process |
GO_0006954 | Biological process | inflammatory response |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0045087 | Biological process | innate immune response |
GO_0009986 | Cellular component | cell surface |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0050431 | Molecular function | transforming growth factor beta binding |
GO_0141069 | Molecular function | receptor ligand inhibitor activity |
Gene name | NRROS |
Protein name | Transforming growth factor beta activator LRRC33 (Leucine-rich repeat-containing protein 33) (Negative regulator of reactive oxygen species) |
Synonyms | UNQ3030/PRO9833 LRRC33 |
Description | FUNCTION: Key regulator of transforming growth factor beta-1 (TGFB1) specifically required for microglia function in the nervous system (By similarity). Required for activation of latent TGF-beta-1 in macrophages and microglia: associates specifically via disulfide bonds with the Latency-associated peptide (LAP), which is the regulatory chain of TGFB1, and regulates integrin-dependent activation of TGF-beta-1 (By similarity). TGF-beta-1 activation mediated by LRRC33/NRROS is highly localized: there is little spreading of TGF-beta-1 activated from one microglial cell to neighboring microglia, suggesting the existence of localized and selective activation of TGF-beta-1 by LRRC33/NRROS (By similarity). Indirectly plays a role in Toll-like receptor (TLR) signaling: ability to inhibit TLR-mediated NF-kappa-B activation and cytokine production is probably a consequence of its role in TGF-beta-1 signaling . . |
Accessions | Q86YC3 ENST00000328557.5 |